狂犬病暴露前后预防接种的免疫原性:系统综述与剂量-反应荟萃分析
该系统综述与剂量-反应荟萃分析检索4个数据库至2020年1月,纳入80项狂犬病暴露前和暴露后预防研究、191个数据集、12413名参与者,汇总几何平均滴度(GMT)随时间的变化。结果显示皮内和肌内接种均产生足够GMT,>50岁人群GMT显著低于<50岁人群,1周短程方案与3至12周长程方案效果相当。
要点
- 皮内和肌内暴露前后预防接种均产生足够GMT。
- >50岁人群GMT显著低于<50岁人群,需特别关注。
- 1周短程方案与3至12周长程方案效果相当。
核心结论
- 多种皮内和肌内方案均有效,选择方案需考虑患者需求、费用、后续接种可及性和完成时间。
- 老年人抗体反应较低,应特别关注。
研究设计与样本
- 系统综述与剂量-反应荟萃分析,检索4个数据库自建库至2020年1月。
- 纳入80项狂犬病暴露前和暴露后预防研究,共191个数据集、12413名参与者。
主要发现
- 皮内和肌内暴露前后预防接种均产生足够GMT。
- >50岁参与者GMT显著低于<50岁参与者。
- 1周短程方案与3至12周长程方案效果相当。
关键数值与推荐
- 按接种途径、年龄组和方案进行亚组分析。
临床怎么用
- 选择方案时综合考虑患者需求、费用、后续接种可及性和完成时间。
- 对老年人应特别关注其较低的抗体反应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There are a myriad of vaccine schedules for rabies pre- (PrEP) and post-exposure prophylaxis (PEP) that differ in the number and timedoses, number of visits, length of schedule, and route of administration. The objective of this study was to systematically review the evidence and investigate how thedifferences in schedules influence titres over time. METHODS: Four databaseswere searched from inception to January 2020 for rabies PrEP and PEP studies. Adose-response meta-analysis was utilised to pool geometric mean titres (GMT) over time. Subgroup analyses by route of administration, age group, and schedule were conducted. RESULTS: 80 studies met the inclusion criteria and contributed with 191 datasets and 12,413 participants. Both intradermal (ID) and intramuscular (IM) PrEP/PEP produce adequate GMTs. Significantly lower GMT levels were achieved in older (>50yrs) compared to younger (<50yrs) participants. Short 1-week schedules were as effective as longer schedules that can take between 3 and 12 weeks to complete. CONCLUSIONS: Several effective ID and IM schedules were identified, the selection of a schedule should take into account the patient's needs, costs, availability to return for subsequent doses, and the time required to complete the schedule. Older individuals warrant special attention as they develop lower antibody response.
引用
- Xu C, Lau CL, Clark J, et al. Immunogenicity after pre- and post-exposure rabies vaccination: A systematic review and dose-response meta-analysis. Vaccine. 2021. PMID: 33478786. doi:10.1016/j.vaccine.2021.01.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。